Lipid-lowering drugs
- 29 March 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 63 (10), 1165-1178
- https://doi.org/10.1007/s00018-005-5406-7
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Long-term statin use and psychological well-beingJournal of the American College of Cardiology, 2003
- Gemfibrozil, a Lipid-lowering Drug, Inhibits the Induction of Nitric-oxide Synthase in Human AstrocytesJournal of Biological Chemistry, 2002
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- Pitavastatin Enhanced BMP-2 and Osteocalcin Expression by Inhibition of Rho-Associated Kinase in Human OsteoblastsBiochemical and Biophysical Research Communications, 2001
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.JCI Insight, 1998
- Cooperative Formation of Higher Order Peroxisome Proliferator-activated Receptor and Retinoid X Receptor Complexes on the Peroxisome Proliferator Responsive Element of the Rat Hydratase-Dehydrogenase GeneOnline Journal of Public Health Informatics, 1995
- The role of peroxisomes in mammalian cellular metabolismJournal of Inherited Metabolic Disease, 1987
- Replication of arterial smooth muscle cells in hypertension and atherosclerosisThe American Journal of Cardiology, 1987
- Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.The Journal of cell biology, 1975